Effects of co-administration of dietary sodium arsenite and an NADPH oxidase inhibitor on the rat bladder epithelium

Shugo Suzuki, Lora L Arnold, Karen L. Pennington, Satoko Kakiuchi-Kiyota, Samuel Monroe Cohen

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Arsenite (AsIII), an inorganic arsenical, is a known human carcinogen, inducing tumors of the skin, urinary bladder and lung. It is metabolized to organic methylated arsenicals. Oxidative stress has been suggested as a mechanism for arsenic-induced carcinogenesis. Reactive oxygen species (ROS) can be important factors for carcinogenesis and tumor progression. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase is known to produce intracellular ROS, therefore, we investigated the ability of apocynin (acetovanillone), an NADPH oxidase inhibitor, to inhibit the cytotoxicity and regenerative cell proliferation of arsenic in vitro and in vivo. Apocynin had similar effects in reducing the cytotoxicity of AsIII and dimethylarsinous acid (DMAIII) in rat urothelial cells in vitro. When tested at the same concentrations as apocynin, other antioxidants, such as l-ascorbate and N-acetylcysteine, did not inhibit AsIII-induced cytotoxicity but they were more effective at inhibiting DMAIII-induced cytotoxicity compared with apocynin. In vivo, female rats were treated for 3 weeks with 100 ppm AsIII. Immunohistochemical staining for 8-hydroxy-2′-deoxyguanosine (8-OHdG) showed that apocynin reduced oxidative stress partially induced by AsIII treatment on rat urothelium, and significantly reduced the cytotoxicity of superficial cells detected by scanning electron microscopy (SEM). However, based on the incidence of simple hyperplasia and the bromodeoxyuridine (BrdU) labeling index, apocynin did not inhibit AsIII-induced urothelial cell proliferation. These data suggest that the NADPH oxidase inhibitor, apocynin, may have the ability to partially inhibit arsenic-induced oxidative stress and cytotoxicity of the rat bladder epithelium in vitro and in vivo. However, apocynin did not inhibit the regenerative cell proliferation induced by arsenite in a short-term study.

Original languageEnglish (US)
Pages (from-to)41-46
Number of pages6
JournalToxicology
Volume261
Issue number1-2
DOIs
StatePublished - Jun 30 2009

Fingerprint

Dietary Sodium
NADP
Rats
Oxidoreductases
Urinary Bladder
Epithelium
Cytotoxicity
Oxidative stress
Cell proliferation
Arsenic
Arsenicals
Oxidative Stress
Cell Proliferation
Tumors
Reactive Oxygen Species
Carcinogenesis
acetovanillone
sodium arsenite
Urothelium
Acetylcysteine

Keywords

  • Arsenite (As)
  • Dimethylarsinous acid (DMA)
  • Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase
  • Urinary bladder
  • Urothelial cell cytotoxicity

ASJC Scopus subject areas

  • Toxicology

Cite this

Effects of co-administration of dietary sodium arsenite and an NADPH oxidase inhibitor on the rat bladder epithelium. / Suzuki, Shugo; Arnold, Lora L; Pennington, Karen L.; Kakiuchi-Kiyota, Satoko; Cohen, Samuel Monroe.

In: Toxicology, Vol. 261, No. 1-2, 30.06.2009, p. 41-46.

Research output: Contribution to journalArticle

@article{f5c700d177834b0eb3f45d07ca545d27,
title = "Effects of co-administration of dietary sodium arsenite and an NADPH oxidase inhibitor on the rat bladder epithelium",
abstract = "Arsenite (AsIII), an inorganic arsenical, is a known human carcinogen, inducing tumors of the skin, urinary bladder and lung. It is metabolized to organic methylated arsenicals. Oxidative stress has been suggested as a mechanism for arsenic-induced carcinogenesis. Reactive oxygen species (ROS) can be important factors for carcinogenesis and tumor progression. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase is known to produce intracellular ROS, therefore, we investigated the ability of apocynin (acetovanillone), an NADPH oxidase inhibitor, to inhibit the cytotoxicity and regenerative cell proliferation of arsenic in vitro and in vivo. Apocynin had similar effects in reducing the cytotoxicity of AsIII and dimethylarsinous acid (DMAIII) in rat urothelial cells in vitro. When tested at the same concentrations as apocynin, other antioxidants, such as l-ascorbate and N-acetylcysteine, did not inhibit AsIII-induced cytotoxicity but they were more effective at inhibiting DMAIII-induced cytotoxicity compared with apocynin. In vivo, female rats were treated for 3 weeks with 100 ppm AsIII. Immunohistochemical staining for 8-hydroxy-2′-deoxyguanosine (8-OHdG) showed that apocynin reduced oxidative stress partially induced by AsIII treatment on rat urothelium, and significantly reduced the cytotoxicity of superficial cells detected by scanning electron microscopy (SEM). However, based on the incidence of simple hyperplasia and the bromodeoxyuridine (BrdU) labeling index, apocynin did not inhibit AsIII-induced urothelial cell proliferation. These data suggest that the NADPH oxidase inhibitor, apocynin, may have the ability to partially inhibit arsenic-induced oxidative stress and cytotoxicity of the rat bladder epithelium in vitro and in vivo. However, apocynin did not inhibit the regenerative cell proliferation induced by arsenite in a short-term study.",
keywords = "Arsenite (As), Dimethylarsinous acid (DMA), Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, Urinary bladder, Urothelial cell cytotoxicity",
author = "Shugo Suzuki and Arnold, {Lora L} and Pennington, {Karen L.} and Satoko Kakiuchi-Kiyota and Cohen, {Samuel Monroe}",
year = "2009",
month = "6",
day = "30",
doi = "10.1016/j.tox.2009.04.042",
language = "English (US)",
volume = "261",
pages = "41--46",
journal = "Toxicology",
issn = "0300-483X",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Effects of co-administration of dietary sodium arsenite and an NADPH oxidase inhibitor on the rat bladder epithelium

AU - Suzuki, Shugo

AU - Arnold, Lora L

AU - Pennington, Karen L.

AU - Kakiuchi-Kiyota, Satoko

AU - Cohen, Samuel Monroe

PY - 2009/6/30

Y1 - 2009/6/30

N2 - Arsenite (AsIII), an inorganic arsenical, is a known human carcinogen, inducing tumors of the skin, urinary bladder and lung. It is metabolized to organic methylated arsenicals. Oxidative stress has been suggested as a mechanism for arsenic-induced carcinogenesis. Reactive oxygen species (ROS) can be important factors for carcinogenesis and tumor progression. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase is known to produce intracellular ROS, therefore, we investigated the ability of apocynin (acetovanillone), an NADPH oxidase inhibitor, to inhibit the cytotoxicity and regenerative cell proliferation of arsenic in vitro and in vivo. Apocynin had similar effects in reducing the cytotoxicity of AsIII and dimethylarsinous acid (DMAIII) in rat urothelial cells in vitro. When tested at the same concentrations as apocynin, other antioxidants, such as l-ascorbate and N-acetylcysteine, did not inhibit AsIII-induced cytotoxicity but they were more effective at inhibiting DMAIII-induced cytotoxicity compared with apocynin. In vivo, female rats were treated for 3 weeks with 100 ppm AsIII. Immunohistochemical staining for 8-hydroxy-2′-deoxyguanosine (8-OHdG) showed that apocynin reduced oxidative stress partially induced by AsIII treatment on rat urothelium, and significantly reduced the cytotoxicity of superficial cells detected by scanning electron microscopy (SEM). However, based on the incidence of simple hyperplasia and the bromodeoxyuridine (BrdU) labeling index, apocynin did not inhibit AsIII-induced urothelial cell proliferation. These data suggest that the NADPH oxidase inhibitor, apocynin, may have the ability to partially inhibit arsenic-induced oxidative stress and cytotoxicity of the rat bladder epithelium in vitro and in vivo. However, apocynin did not inhibit the regenerative cell proliferation induced by arsenite in a short-term study.

AB - Arsenite (AsIII), an inorganic arsenical, is a known human carcinogen, inducing tumors of the skin, urinary bladder and lung. It is metabolized to organic methylated arsenicals. Oxidative stress has been suggested as a mechanism for arsenic-induced carcinogenesis. Reactive oxygen species (ROS) can be important factors for carcinogenesis and tumor progression. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase is known to produce intracellular ROS, therefore, we investigated the ability of apocynin (acetovanillone), an NADPH oxidase inhibitor, to inhibit the cytotoxicity and regenerative cell proliferation of arsenic in vitro and in vivo. Apocynin had similar effects in reducing the cytotoxicity of AsIII and dimethylarsinous acid (DMAIII) in rat urothelial cells in vitro. When tested at the same concentrations as apocynin, other antioxidants, such as l-ascorbate and N-acetylcysteine, did not inhibit AsIII-induced cytotoxicity but they were more effective at inhibiting DMAIII-induced cytotoxicity compared with apocynin. In vivo, female rats were treated for 3 weeks with 100 ppm AsIII. Immunohistochemical staining for 8-hydroxy-2′-deoxyguanosine (8-OHdG) showed that apocynin reduced oxidative stress partially induced by AsIII treatment on rat urothelium, and significantly reduced the cytotoxicity of superficial cells detected by scanning electron microscopy (SEM). However, based on the incidence of simple hyperplasia and the bromodeoxyuridine (BrdU) labeling index, apocynin did not inhibit AsIII-induced urothelial cell proliferation. These data suggest that the NADPH oxidase inhibitor, apocynin, may have the ability to partially inhibit arsenic-induced oxidative stress and cytotoxicity of the rat bladder epithelium in vitro and in vivo. However, apocynin did not inhibit the regenerative cell proliferation induced by arsenite in a short-term study.

KW - Arsenite (As)

KW - Dimethylarsinous acid (DMA)

KW - Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase

KW - Urinary bladder

KW - Urothelial cell cytotoxicity

UR - http://www.scopus.com/inward/record.url?scp=66049093024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66049093024&partnerID=8YFLogxK

U2 - 10.1016/j.tox.2009.04.042

DO - 10.1016/j.tox.2009.04.042

M3 - Article

C2 - 19397947

AN - SCOPUS:66049093024

VL - 261

SP - 41

EP - 46

JO - Toxicology

JF - Toxicology

SN - 0300-483X

IS - 1-2

ER -